← Back to headlines
Hims & Hers Stock Rallies on Peptide Pipeline and Novo Nordisk Deal Hopes
Hims & Hers shares surged 9% as investors showed strong confidence in the company's peptide pipeline and a potential deal with Novo Nordisk.
20 Apr, 14:40 — 20 Apr, 14:40
Sources
Showing 1 of 1 sources
Related Stories
Health experts call for workplace measures to curb burnout
just now
Dangerous heat index hits 11 areas, peaks at 45ºC in Pili, Camarines Sur
2m ago
Dominant understanding of the origins of COVID-19 on the defendant's bench
17m ago
Former Fauci adviser indicted for allegedly concealing communications related to COVID-19 research
17m ago